InMode specializes in making equipment for less-invasive aesthetic procedures. Medtronic is one of the largest equipment makers in the world. Medtronic offers an above-average dividend. Medical stocks ...

InMode Ltd. boasts superior fundamentals, yet trades at undervalued market multiples due to its unique risk profile. The company is a leader in the global aesthetics market with proprietary RF-based ...

InMode machines provide a platform for noninvasive cosmetic procedures. The potential for new market entrants and lack of recurring revenue is concerning. Traditional cosmetic surgery is expensive, ...

We are writing to make you aware that we have expressed interest to InMode’s leadership in pursuing an acquisition by Steel Partners of 51% of the Company’s outstanding shares for $18.00 per share, ...

These projections put the company in a fairly good position and indicate that on the low side InMode is near fair value, but on the high side has a lot of potential. Showing these various cases, ...

There were two different stories for InMode (NASDAQ: INMD) in 2022. In the first half of the year, the medical device stock plunged 68%. However, in the second half, InMode roared back, with its ...

InMode (NASDAQ:INMD) is gearing up to announce its quarterly earnings on Tuesday, 2026-02-10. Here's a quick overview of what investors should know before the release. Analysts are estimating that ...

InMode Ltd INMD shares are trading lower Tuesday after the company reported better-than-expected results, but issued a weak earnings forecast. InMode noted that its proprietary surgical technology ...

InMode Ltd. (INMD) reported its Q4 2025 earnings, surpassing analyst expectations with earnings per share (EPS) of $0.46, outperforming the forecast of $0.42. The company’s revenue also exceeded ...

Let's talk about what we know about cosmetic surgery. First, it's costly. It's invasive, leaves scars, and has long recovery times. Cosmetic surgery is mostly for the rich and famous -- not regular ...